Marvel Biosciences Corp Defensive Interval Ratio
Marvel Biosciences Corp defensive interval ratio. Marvel Biosciences Corp (MRVL) has a Defensive Interval Ratio of 28 days as of April 2023. Defensive assets of CA$69.36K (cash CA$-, short-term investments CA$-, receivables CA$69.36K) cover 28 days of daily cash needs of CA$2.47K/day. See MRVL current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Marvel Biosciences Corp (2020–2022)
Defensive interval ratio of Marvel Biosciences Corp from 2020 to 2022. This chart shows how Marvel Biosciences Corp's Defensive Interval Ratio has evolved across 3 annual periods from 2020 to 2022. As of April 2023, the ratio stands at 28 days, meaning defensive assets of CA$69.36K can fund 28 days of operations without new revenue. Read Marvel Biosciences Corp (MRVL) financial obligations for a breakdown of total debt and financial obligations.
Marvel Biosciences Corp Defensive Interval Ratio by Year (2020–2022)
Marvel Biosciences Corp defensive interval ratio by year from 2020 to 2022. The table below presents the year-by-year Defensive Interval Ratio for Marvel Biosciences Corp from 2020 to 2022, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Marvel Biosciences Corp total assets.
| Year | DIR (days) | Defensive Assets (CAD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2022 | 29 days | CA$56.44K | CA$1.97K/day | CA$- | CA$- | ▼ -163 days |
| 2021 | 192 days | CA$59.11K | CA$308.16/day | CA$- | CA$- | ▲ +118 days |
| 2020 | 74 days | CA$35.84K | CA$485.43/day | CA$- | CA$- | — |